Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations andDisclosure Requirements) Regulations, 2015 (SEBI Listing Regulations)
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medplus Health Services has informed the stock exchanges that it has received two Stay Orders from appropriate authorities in Pune, Maharashtra, against an earlier suspension referenced in its submissions dated April 22, 2025 and May 27, 2025. While the exact nature of the suspension is not detailed in this filing, it likely relates to regulatory action concerning the company's pharmacy/retail operations. A stay order means the suspension has been temporarily paused by the court/authority pending further hearing. The company has stated that further details will be available on its website and the BSE/NSE portals.
This is a positive development for shareholders as the stay orders provide temporary relief from the suspension, allowing Medplus to continue normal operations until the matter is resolved. However, the underlying regulatory issue is still pending, so the final outcome remains uncertain and could still pose a risk if the stay is vacated.